1.Atagun MI, Balaban OD, Lordoglu DY, Evren EC. Lithium and valproate may affect motor and sensory speed in patients with bipolar disorder. The Bulletin of Clinical Psychopharmacology 2013; 23:305-314.

2.Atagun MI, Oral ET, Sevinc C. Polycystic kidney disease in a patient using lithium chronically. Turk Psikiyatri Derg 2013; 24:213.

3.Patel M, Harrison S, Sinclair R. Drugs and hair loss. Dermatol Clin 2013; 31:67-73.

4.Suzuki T, Koizumi J, Moroji T, Shiraishi H, Hori T, Baba A, Kawai N, Tada K.. Effects of long-term anticonvulsant therapy on copper, zinc, and magnesium in hair and serum of epileptics. Biol Psychiatry 1992; 31:571–581.

5.Stroud JD. Diagnosis and management of the hair loss patient. Cutis 1987; 40:272–276.

6.Wichniak A, Jarkiewicz M, Okruszek Ł, Wierzbicka 3, Holka-Pokorska J, Rybakowski JK. Low risk for switch to mania during treatment with sleep promoting antidepressants. Pharmacopsychiatry 2015; 25:83-88.

7.De Bodinat C, Guardiola-Lemaitre B, Mocaër E, Renard P, Muñoz C, Millan MJ. Agomelatine, the first melatonergic antidepressant: discovery, characterization and development. Nat Rev Drug Discov 2010; 9:628-642.

8.Grover C, Khurana A. Telogen effluvium. Indian J Dermatol Venereol Leprol 2013; 79:591.

9.Singh M, Jadhav HR. Melatonin: functions and ligands. Drug Discov Today 2014; 19:1410-1418.

10.Fischer TW, Slominski A, Tobin DJ, Paus R. Melatonin and the hair follicle. J Pineal Res 2008; 44:1-5.